| Antidiabetic drugs and statins in nonalcoholic fatty liver disease S Kothari, H Dhami-Shah, SR Shah Journal of clinical and experimental hepatology 9 (6), 723-730, 2019 | 62 | 2019 |
| FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease S Shah, H Dhami-Shah, S Kamble, A Shukla Journal of Hepatology 73 (1), 216-217, 2020 | 32 | 2020 |
| Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis H Dhami-Shah, R Vaidya, S Udipi, S Raghavan, S Abhijit, V Mohan, ... Clinical and molecular hepatology 24 (1), 77, 2018 | 31 | 2018 |
| Picrorhiza kurroa, Royle ex Benth: Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease A Raut, H Dhami-Shah, A Phadke, A Shindikar, S Udipi, J Joshi, R Vaidya, ... Journal of Ayurveda and Integrative Medicine 14 (1), 100558, 2023 | 14 | 2023 |
| A Randomized Controlled Facility Based Trial to Assess the Impact of Indigenously Prepared Ready to Use Therapeutic Food (RUTF) for Children with Severe Acute Malnutrition in India MM Alka Jadhav*, Bina Dias*, Narendra Shah**, Lavina Fernandes*, Sneha ... Pediatric Oncall Journal 13 (4), 2016 | 10* | 2016 |
| Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells. VADB Dhami-Shah H, Vaidya R, Talwadekar M, Shaw E, Udipi S, Kolthur-Seetharam U J Ayurveda Integr Med 3 (12), 465 - 473, 2021 | 9* | 2021 |
| Non-alcoholic fatty liver disease: A practical guide H Dhami-Shah, RA Vaidya Journal of Obesity and Metabolic Research 1 (1), 62, 2014 | 3 | 2014 |
| Natural medicines: categories, comebacks and catalysts A Vaidya, H Dhami-Shah, S Udipi Natural Medicines, 481-492, 2019 | 2 | 2019 |
| Dr. Ancel Benjamin Keys (1904-2004): Monsieur cholesterol and a driven interventionist A Vaidya, H Dhami-Shah Journal of Obesity and Metabolic Research 2 (3), 179-179, 2015 | 2 | 2015 |
| Non Alcoholic Fatty Liver Disease (NAFLD) an Emerging Public Health Challenge R Vaidya, H Dhami The Indian Practitioner 66 (4), 2013 | 1 | 2013 |
| PHENOTYPIC CLUSTERING IDENTIFIES HIGH-RISK PROFILES FOR SARCOPENIA & 1-YEAR POST-TRANSPLANT MORTALITY IN PATIENTS WITH END-STAGE LIVER DISEASE H Dhami-Shah, G Pranesh, D Mogre, A Mandot, R Badhe, P Garde, ... HEPATOLOGY 78, S237-S238, 2023 | | 2023 |
| MR ELASTOGRAPHY CAN RELIABLY PREDICT PORTOSYSTEMIC COLLATERALS IN NON ALCOHOLIC FATTY LIVER DISEASE A Mandot, T Chipkar, H Dhami-Shah, G Pranesh, R Badhe, SR Shah HEPATOLOGY 78, S841-S841, 2023 | | 2023 |
| Identification of High-Risk Sarcopenic Phenotypes in End-Stage Liver Disease & Their Association With 1-Year Post-Transplant Mortality H Dhami-Shah, G Pranesh, D Mogre, R Badhe, A Mandot, P Garde, ... Journal of Clinical and Experimental Hepatology 13, S6-S7, 2023 | | 2023 |
| Prediction of Porto systemic Collaterals using MR Elastography in Non-alcoholic Fatty Liver Disease T Chipkar, A Mandot, H Dhami-Shah, G Pranesh, R Badhe, S Shah Journal of Clinical and Experimental Hepatology 13, S124, 2023 | | 2023 |
| Making excellence a habit: The secret to building a world-class healthcare system in India by V. Mohan. H Dhami-Shah, ADB Vaidya Journal of Ayurveda and Integrative Medicine 13 (2), 100514, 2022 | | 2022 |
| Alternative therapy: An approach to improve endothelial function H Dhami‑Shah Journal of Obesity and Metabolic Research 3 (1), 51-51, 2016 | | 2016 |
| Clinical Perspective of Ayurceuticals: Challenges and Opportunities for Global Health and Well being AV Namyata Pathak, Hiteshi A Shah Clinical Aspects of Functional Foods and Nutraceuticals, 33-50, 2015 | | 2015 |
| Break‑The‑Fast H Dhami‑Shah Journal of Obesity and Metabolic Research 1 (4), 259-259, 2014 | | 2014 |
| Nutrition Essentials for Children Involved in Sports AJ Hiteshi Dhami-Shah Nutrition and Diet for Children Simplified 1, 235-240, 2014 | | 2014 |
| Insights into the molecular actions of metformin and the future targets for research H Dhami‑Shah Immune Netw 13 (4), 123-32, 2013 | | 2013 |